Overview Executive Committee Supervisory Board Locations
Overview Satraplatin Kinase Inhibitors
Stock Key Figures Financial Reports SEC Filings

Corporate Governance

Analyst Coverage Shareholder´s Meeting Webcasts Information Request
Press Releases Contact Information
Working for GPC Biotech Germany USA

More Info

Corporate Governance Declarations

Code of Conduct

Disclosure Committee

Management and Control Structures

Compensation of the Boards

Shareholdings of the Boards

Directors' Dealings

Print preview

Print

Investor Relations


Corporate Governance

Strong Commitment to Corporate Governance

 

GPC Biotech places strong importance on good corporate governance. The Company’s framework for corporate governance is based upon applicable law and stock market self-regulation in both Germany and the U.S. and upon Company-specific principles. Essential elements of good corporate governance include respect for the int erests of shareholders, effective cooperation between the Management Board and Supervisory Board, and open and transparent communication.

 

As part of GPC Biotech’s own corporate governance principles, in
2007 the Company complied with all of the newly recommended
changes to the German Corporate Governance Codex proposed by the German Corporate Governance Commission on June 14, 2007. GPC Biotech’s corporate governance principles incorporate both German legal requirements and the recommendations of the Codex.


The Company also complies with the corporate governance requirements of the Frankfurt Stock Exchange and with U.S. legal requirements, including those in the Sarbanes-Oxley Act of 2002 for foreign filers and the corporate governance rules of NASDAQ.


Corporate Governance Principles

  Acrobat Reader Document, approx. 0.2 MB 

  

 

 

  


 

 

 

Investor Relations | Corporate Governance